Richard Lippman, M.D.

Born December 18, 1944 in Stockholm, Sweden, Dr. Lippman attended Sveaplan Vuxen Gymnasium where he graduated with honors in all courses. After attending Arizona State University and Cornell University and graduating with a Bachelor of Science degree in 1968, he was employed as a chemical researcher at the Royal Institute of Technology, Stockholm. He attended medical school at Biomedicum, Uppsala, Sweden, where he specialized in measurement and monitoring of free radicals and their effects upon aging at the Departments of Histology and Medical Cell Biology. Dr. Lippman is a member of the Swedish Medical Association. He has authored over 37 peer-reviewed scientific articles in leading gerontological journals such as Experimental Gerontology, Mechanisms of Ageing and Development, the Journal of Gerontology, and others. In 1984, he invented the nicotine patch. He has led clinical double-blind, cross-over investigations, especially in regard to transdermal Vitamin B12, weight loss, and melatonin patches. In 1985, he invented the first jet-lag kit employing the then unknown hormone, melatonin. In 1987, he was awarded numerous world patents for the special free-radical inhibitor, NDGA. This invention yielded the only patent ever awarded by the US Patent Office with claims to retard human aging. During the ‘80s, he invented two separate non-invasive methods that probe and monitor cascading free radicals in vivo in both humans and lab animals. In recognition of these last two achievements, Dr. Lippman was nominated for the Nobel Prize in Medicine in 1996. Dr. Lippman has written over 50 anti-aging articles for International Antiaging Systems Ltd, United Kingdom. Despite semi-retirement, Dr. Lippman continues to lecture, write, and conduct anti-aging research.

Non-CME faculty.